Cardiff Oncology, Inc. short interest in 2025
In 2025, Cardiff Oncology, Inc.'s disclosed short interest ran from 18.53% of shares outstanding on 15 Jan 2025 to 23.24% on 31 Dec 2025, a change of +4.71 percentage points. The year's high was 34.18% on 30 Apr 2025 and its low 18.53% on 15 Jan 2025, averaging 24.87% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.71 days on 15 May 2025. Full history: Cardiff Oncology, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 18.53% (15 Jan 2025)
- End of year
- 23.24% (31 Dec 2025)
- Change
- +4.71 pp
- High
- 34.18% (30 Apr 2025)
- Low
- 18.53% (15 Jan 2025)
- Average
- 24.87%
- Highest days to cover
- 22.71 (15 May 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 18.53% | 7.37 | |
| 31 Jan 2025 | 20.44% | 11.09 | |
| 14 Feb 2025 | 21.20% | 12.78 | |
| 28 Feb 2025 | 22.26% | 9.12 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 26.09% | 11.71 | |
| 31 Mar 2025 | 28.97% | 13.29 | |
| 15 Apr 2025 | 33.90% | 9.68 | |
| 30 Apr 2025 | 34.18% | 16.10 | |
| 15 May 2025 | 26.34% | 22.71 | 10-Q filed, results (8-K) |
| 30 May 2025 | 26.51% | 20.49 | |
| 13 Jun 2025 | 25.99% | 14.55 | |
| 30 Jun 2025 | 27.63% | 12.13 | |
| 15 Jul 2025 | 28.40% | 14.23 | |
| 31 Jul 2025 | 28.32% | 4.81 | 10-Q filed, results (8-K) |
| 15 Aug 2025 | 23.61% | 8.23 | |
| 29 Aug 2025 | 23.91% | 15.74 | |
| 15 Sep 2025 | 22.94% | 12.87 | |
| 30 Sep 2025 | 22.81% | 20.41 | |
| 15 Oct 2025 | 21.44% | 15.19 | |
| 31 Oct 2025 | 21.16% | 18.76 | |
| 14 Nov 2025 | 22.01% | 21.46 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 23.14% | 19.71 | |
| 15 Dec 2025 | 23.95% | 15.65 | |
| 31 Dec 2025 | 23.24% | 14.39 |
See also: Cardiff Oncology, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.